QOL MEDICAL LLC
QOL Medical, LLC (“the Company”) is committed to compliance with applicable federal and state laws. QOL Medical has developed policies and procedures that ...|QOL Medical is a specialty biopharmaceutical company dedicated to improving each patient's life. We focus on solving complex, rare disease challenges with ...|About QOL Medical, LLC · QOL Medical is a specialty biopharmaceutical company dedicated to improving each patient's life. We focus on solving complex, rare ...|This privacy policy (“Privacy Policy” or “Policy”) describes QOL Medical policies on the collection, use and disclosure of personal information ...|Do Not Sell/Share My Personal Information ... Please fill out this form to submit a “Do Not Sell/Share My Personal Information” request.|QOL Medical is formed under the laws of the State of Delaware with its headquarter offices located at 3405 Ocean Dr., Vero Beach, FL 32963.|QOL Medical is interested in acquiring (or partnering on) biopharmaceutical products for the treatment of rare diseases. We are interested in commercial ...
Country/Area ：United States
Company Email ：hr@qolmed.com
Industry ：Health & MedicalHealthcarePharmaceuticalMachineryPharmaceuticals
Company address ：11236 47TH STREETN CLEARWATER FL 33762 USA
Company website ：*****
Company phone ：1-866-469-3773
Established ：2003-01-01
Company Revenue ：$15,562,000
Number of employees ：4
SIC Code ：80809
NAICS Code ：62621
Main Products ：CompliancePartnering with QOL MedicalEthamolin ® (ethanolamine oleate) Injection, 5%.
Company News
World IBS Day April 19th: Raising Awareness and Reducing Stigma of Irritable Bowel Syndrome
Apr 18, 2023
With over 800 million worldwide IBS sufferers TORONTO, April 18, 2023 /PRNewswire/ -- April 19th marks World IBS Day, an international day of awareness for those living with Irritable Bowel Syndrome (IBS). With the support of QOL Medical – CSID, this day is dedicated to raising awareness...
Apr 18, 2023
QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID)Sep 6, 2022
VERO BEACH, Fla., Sept. 6, 2022 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, announced today that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid® single-use containers for patients more than 33 lb (15 kg) with...
Sep 6, 2022QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral SolutionApr 15, 2022
VERO BEACH, Fla., April 15, 2022 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, announced today it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral...
Apr 15, 2022Food Sensitivity Symptoms May Be Caused by Sucrose Intolerance: Fourth Annual National Sucrose Intolerance Awareness Week April 11-17, 2022Apr 12, 2022
VERO BEACH, Fla., April 12, 2022 /PRNewswire/ -- QOL Medical, LLC today announced their theme for the 4th annual National Sucrose Intolerance Awareness Week, from April 11-17, 2022. This year's theme, "Is Sucrose Intolerance Real?" was selected based on one of the top Goggled questions in...
Apr 12, 2022Cast Covers Market to See Huge Growth by 2026 : United Ortho, QOL Medical, Innovation RehabMay 20, 2021
Edison, NJ -- (SBWIRE) -- 05/20/2021 -- What's Ahead in the Global Cast Covers Market? Benchmark yourself with strategic steps and conclusions recently published by AMA Read the full press release at http://www.sbwire.com/press-releases/cast-covers-market-to-see-huge-growth-by-2026-united-ortho-qol-medical-innovation-rehab-1339906.htm
May 20, 2021Web Summary
Q1: What is the address of QOL Medical LLC's manufacturing facility?
A1: The address of QOL Medical LLC's manufacturing facility is 3405 Ocean Drive, Vero Beach, FL 32963.
Q2: What are the two FDA-approved products currently marketed by QOL Medical LLC?
A2: The two FDA-approved products currently marketed by QOL Medical LLC are Sucraid ® (sacrosidase) Oral Solution and Ethamolin ® (ethanolamine oleate) Injection, 5%.
Q3: In what year was QOL Medical LLC founded?
A3: QOL Medical LLC was founded in 2003.
Q4: What is the focus of QOL Medical LLC's product development efforts?
A4: QOL Medical LLC focuses on solving complex, rare disease challenges with elegant solutions and aims to change the world, one patient at a time.
Q5: What type of products does QOL Medical LLC currently market for the treatment of rare and orphan diseases?
A5: QOL Medical LLC currently markets two types of products: Sucraid ® (sacrosidase) Oral Solution and Ethamolin ® (ethanolamine oleate) Injection, 5%.
Q6: What is the company's policy on partnering with biopharmaceutical companies for the treatment of rare diseases?
A6: QOL Medical LLC is interested in acquiring or partnering on biopharmaceutical products for the treatment of rare diseases.
Q7: How can patients access information about QOL Medical LLC's products and services?
A7: Patients can contact QOL Medical LLC at 1-866-469-3773 or visit their website at info@qolmed.com to learn more about their products and services.
Q8: What is the company's commitment to patient access and quality of life in the treatment of rare and orphan diseases?
A8: QOL Medical LLC ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases.
A1: The address of QOL Medical LLC's manufacturing facility is 3405 Ocean Drive, Vero Beach, FL 32963.
Q2: What are the two FDA-approved products currently marketed by QOL Medical LLC?
A2: The two FDA-approved products currently marketed by QOL Medical LLC are Sucraid ® (sacrosidase) Oral Solution and Ethamolin ® (ethanolamine oleate) Injection, 5%.
Q3: In what year was QOL Medical LLC founded?
A3: QOL Medical LLC was founded in 2003.
Q4: What is the focus of QOL Medical LLC's product development efforts?
A4: QOL Medical LLC focuses on solving complex, rare disease challenges with elegant solutions and aims to change the world, one patient at a time.
Q5: What type of products does QOL Medical LLC currently market for the treatment of rare and orphan diseases?
A5: QOL Medical LLC currently markets two types of products: Sucraid ® (sacrosidase) Oral Solution and Ethamolin ® (ethanolamine oleate) Injection, 5%.
Q6: What is the company's policy on partnering with biopharmaceutical companies for the treatment of rare diseases?
A6: QOL Medical LLC is interested in acquiring or partnering on biopharmaceutical products for the treatment of rare diseases.
Q7: How can patients access information about QOL Medical LLC's products and services?
A7: Patients can contact QOL Medical LLC at 1-866-469-3773 or visit their website at info@qolmed.com to learn more about their products and services.
Q8: What is the company's commitment to patient access and quality of life in the treatment of rare and orphan diseases?
A8: QOL Medical LLC ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
